It's Regarded as a Breakthrough Treatment for Depression — so Why Are Oregon’s Psilocybin Centers Closing?
8 Articles
8 Articles
Psilocybin’s acute and persistent brain effects: a precision imaging drug trial
Psilocybin (PSIL) is a psychedelic drug and a promising experimental therapeutic for many psychiatric conditions. Precision functional mapping (PFM) combines densely repeated resting state fMRI sampling and individual-specific network mapping to improve signal-to-noise ratio (SNR) and effect size in brain imaging research. We present a randomized cross-over study in which PFM was used to characterize acute and persistent effects of psilocybin or…
It's regarded as a breakthrough treatment for depression — so why are Oregon’s psilocybin centers closing?
Two years after Oregon opened the nation's first therapeutic psilocybin center, the promise of America’s first legal "trip" is struggling to fully take flight.
Neither a panacea nor an illusion, but a powerful tool, which requires rigorous supervision. Psychedelic-assisted therapies (psilocybine from "magic mushrooms", LSD, MDMA...), long marginalized or even demonized, are now entering French hospitals.
Coverage Details
Bias Distribution
- 60% of the sources are Center
To view factuality data please Upgrade to Premium